Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmace...

FDA Drug Recall #D-0601-2018 — Class II — February 13, 2018

Recall Summary

Recall Number D-0601-2018
Classification Class II — Moderate risk
Date Initiated February 13, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Hetero Labs Limited Unit V
Location Jadcherla Mandal, Mahaboob Nagar
Product Type Drugs
Quantity 1764 60-count bottles

Product Description

Valganciclovir Tablets, USP, 450 mg, 60-count bottle, Rx Only, Manufactured for Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, By: Hetero Hetero Labs Limit Unit V Pollypally Jadcherla Mahaboob Nagar - 509 301 India. NDC # 31722-832-60

Reason for Recall

Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).

Distribution Pattern

NJ and then distributed Nationwide in the USA

Lot / Code Information

Lot #s VGC17040 & VGC17041, EXP 07/2019

Other Recalls from Hetero Labs Limited Unit V

Recall # Classification Product Date
D-1213-2018 Class II Montelukast Sodium Tablets, 10 mg*, 30-count bo... Aug 20, 2018
D-0081-2019 Class I Montelukast Sodium Tablets 10 mg, 30-count bott... Aug 15, 2018
D-1116-2018 Class II Camber Pharmaceuticals, Inc. Valsartan Tablets,... Aug 8, 2018
D-1113-2018 Class II Camber Pharmaceuticals, Inc. Valsartan Tablets,... Aug 8, 2018
D-1115-2018 Class II Camber Pharmaceuticals, Inc. Valsartan Tablets,... Aug 8, 2018

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.